Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients.

Author: AliSaira A, BeatyBrenda L, BitterfeldLeandra, BoulwareMary Alice, CampbellKathleen M, CarrEmily, ChangYeh-Chung, ChapmanShelley, CunninghamRyan, DallasRonald H, DantuluriKeerti L, Danziger-IsakovLara A, DomenickBryanna N, EbelNoelle H, ElisofonScott, FawazRima, FeldmanAmy G, FerrolinoJose A, FocaMarc, GansHayley A, GopalareddyVani V, GuCindy, GuptaNitika A, HarmannKatherine, HollenbeckJessica, HupplerAnna R, JaramilloCatalina, KasiNagraj, KerkarNanda, LerretStacee, LobrittoSteven J, LopezMaclovio J, MariniElizabeth, MaronGabriela, MavisAlisha, MehraSonia, MoatsLynnette, MohandasSindhu, MunozFlor M, MysoreKrupa R, OnsanCeren, OvchinskyNadia, PerkinsKerrigan, PostmaStacy, PratscherLauren, RandElizabeth B, RoweRegina K, SchultzDanielle, SearKatherine, SellMegan L, SharmaTanvi, StollJanis, VangMychoua, VillarinDominique, WeaverCarly, WeidnerHillary K, WoodPhoebe, Woodford-BerryOlivia, YanniGeorge

Paper Details 
Original Abstract of the Article :
Live vaccines (measles-mumps-rubella [MMR] and varicella-zoster virus [VZV]) have not been recommended after solid organ transplant due to concern for inciting vaccine strain infection in an immunocompromised host. However, the rates of measles, mumps, and varicella are rising nationally and interna...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570873/

データ提供:米国国立医学図書館(NLM)

Navigating the Safety and Immunogenicity of Live Viral Vaccines in Transplant Recipients

In the realm of [immunology], the [use of live viral vaccines] in [immunocompromised individuals], particularly [pediatric transplant recipients], presents a complex challenge. This study addresses this challenge by investigating the [safety and immunogenicity] of [measles-mumps-rubella (MMR) and varicella-zoster virus (VZV)] vaccines in a [multicenter cohort] of [pediatric transplant recipients]. The researchers found that [live viral vaccines can be safely administered to pediatric transplant recipients], providing important insights into the management of [vaccine-preventable diseases] in this vulnerable population.

Safeguarding Transplant Recipients: A Step Forward in Vaccination

The study's results highlight the importance of [individualized risk-benefit assessments] when considering [live viral vaccination] in [transplant recipients]. The researchers demonstrate that [live viral vaccines can be safely administered under specific circumstances], opening up new possibilities for protecting these individuals from [vaccine-preventable diseases]. This research contributes significantly to the development of evidence-based guidelines for vaccination in this population.

A Stronger Immune System for Transplant Recipients

This study provides reassurance that [live viral vaccines can be safely used to strengthen the immune system] of [pediatric transplant recipients]. This can help protect them from [life-threatening conditions] associated with [vaccine-preventable diseases]. While it is crucial to consider individual factors and risks, the study offers a ray of hope for improving the health and well-being of this vulnerable population.

Dr.Camel's Conclusion

Imagine a delicate desert flower, thriving amidst the harsh conditions of the desert. Similarly, transplant recipients are fragile individuals whose immune systems require careful consideration. This research, like a gentle rain nourishing the desert flower, highlights the importance of individualized care and the potential of safe and effective vaccination strategies for protecting these individuals from preventable illnesses. The study's findings provide valuable insights for improving the long-term health and well-being of transplant recipients, ensuring that they can bloom and thrive in the challenging landscape of their journey.
Date :
  1. Date Completed 2023-10-23
  2. Date Revised 2023-10-25
Further Info :

Pubmed ID

37824141

DOI: Digital Object Identifier

PMC10570873

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.